LXR-α/SCD1-mediated Endoplasmic Reticulum-Mitochondria Crosstalk in Inhibiting Neuronal Ferroptosis after Spinal Cord Injury
Open Access
- 17 December 2025
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 9
Abstract
Spinal cord injury (SCI) causes extensive neuronal loss, in which ferroptosis is critically involved. Although lipid transport at endoplasmic reticulum-mitochondria contact sites (ERMCSs) has been implicated in facilitating ferroptosis, the neuron-specific regulatory mechanisms remain elusive. Here, we show that neuronal ferroptosis is characterized by excessive ERMCS formation. Mechanistically, a systematic screening revealed the down-regulation of stearoyl-CoA desaturase 1 (SCD1), a critical enzyme in the synthesis of monounsaturated fatty acids (MUFAs) in neurons, following SCI (in vivo) or erastin treatment (in vitro). We demonstrated that SCD1 deficiency is the driving force behind aberrant ERMCS expansion, leading to increased lipid peroxidation and neuronal ferroptosis. Conversely, SCD1 overexpression could reverse these effects. Furthermore, we identified liver X receptor alpha (LXRα) as a direct transcriptional activator of SCD1. Pharmacological activation of LXRα with T0901317 upregulated SCD1 expression, which in turn restrained ERMCS formation, elevated MUFA levels, and ultimately inhibited neuronal ferroptosis. In murine SCI models, both adeno-associated virus-mediated neuronal SCD1 overexpression and LXRα agonist treatment effectively mitigated excessive ERMCS, reduced lesion size, preserved neuronal architecture, and improved functional recovery. Collectively, our study establishes the LXRα–SCD1 axis as a novel and druggable pathway for reducing neuronal loss and improving functional recovery by modulating ERMCS-dependent lipid exchange dynamics, revealing promising therapeutic targets after central nervous system trauma.Keywords
This publication has 47 references indexed in Scilit:
- Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and DiseaseFrontiers in Molecular Neuroscience, 2018
- Mitochondrial contact sites as platforms for phospholipid exchangeBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2017
- Oxidized arachidonic and adrenic PEs navigate cells to ferroptosisNature Chemical Biology, 2016
- Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating NeutrophilsCell Metabolism, 2016
- Activation of Liver-X-Receptor α But Not Liver-X-Receptor β Protects Against Myocardial Ischemia/Reperfusion InjuryCirculation: Heart Failure, 2014
- Liver X receptors in lipid metabolism: opportunities for drug discoveryNature Reviews Drug Discovery, 2014
- Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in miceJournal of Clinical Investigation, 2012
- Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317Atherosclerosis, 2008
- A guided tour into subcellular colocalization analysis in light microscopyJournal of Microscopy, 2006
- Regulation of stearoyl-CoA desaturases and role in metabolismProgress in Lipid Research, 2004